Healthcare Press

EU approves AstraZeneca's drug for adjunct use in Type-1 diabetes

  • 📰 ChannelNewsAsia
  • ⏱ Reading Time:
  • 23 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 12%
  • Publisher: 66%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

REUTERS: British drugmaker AstraZeneca Plc said on Monday the European Commission approved its diabetes drug Forxiga for use as an oral supplement ...

REUTERS: British drugmaker AstraZeneca Plc said on Monday the European Commission approved its diabetes drug Forxiga for use as an oral supplement to insulin in adults with a rare type of the disease.

Forxiga can now be used along with insulin in patients with Type-1 diabetes and a Body Mass Index of 27 or more when insulin alone has not been able to control blood sugar levels, the company said. Type-1 diabetes is a chronic condition in which the pancreas produces little or no insulin hormone.Farxiga or Forxiga, as the drug is known outside the United States, is one of AstraZeneca's top ten drugs by sales. It generated US$1.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 6. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Cancer deaths falling for half decade in EU: StudyPARIS: The death rate from cancer has been falling for half a decade in the EU, researchers said Tuesday (Mar 19), although the overall number is ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »